Gabapentin 600mg, Aurobindo Pharma USA, D 24 Pill – white oval

D 24 Pill – white oval, 17mm

Pill with imprint D 24 is White, Oval and has been identified as Gabapentin 600 mg. It is supplied by Aurobindo Pharma USA, Inc.

Gabapentin is used in the treatment of Back Pain; Postherpetic Neuralgia; Epilepsy; Chronic Pain; Seizures and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Gabapentin 600 mg is not a controlled substance under the Controlled Substances Act (CSA).

Gabapentin 600mg, Aurobindo Pharma USA, D 24 Pill - white oval
Gabapentin 600mg, Aurobindo Pharma USA, D 24 Pill – white oval

Gabapentin

Imprint
D 24
Strength
600 mg
Color
White
Size
17.00 mm
Shape
Oval
Availability
Prescription only
Drug Class
Gamma-aminobutyric acid analogs
Pregnancy Category
C – Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma USA, Inc.
Inactive Ingredients
copovidone, corn starch, crospovidone, hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, magnesium silicate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
65862-0523 Aurobindo Pharma Limited
16714-0330 NorthStar Rx LLC

Gabapentin 600mg

Gabapentin 600mg is a prescription medication typically used to treat conditions such as epilepsy, neuropathic pain, and certain types of seizures. If your healthcare provider has prescribed gabapentin 600mg for you, it’s important to follow their instructions carefully. Here are some general guidelines for taking gabapentin 600mg:

  1. Dosage: Take gabapentin exactly as prescribed by your doctor. The typical starting dose for adults is 300mg taken orally twice a day, with the dose gradually increased as needed under your doctor’s supervision. Your doctor will determine the appropriate dose based on your medical condition and response to treatment.
  2. Administration: Gabapentin tablets should be taken orally with plenty of water. Swallow the tablet whole; do not crush, chew, or break it. You can take gabapentin with or without food, but it’s important to take it consistently, either always with food or always on an empty stomach, to maintain consistent drug levels in your body.
  3. Schedule: Take gabapentin at evenly spaced intervals to maintain a constant level of medication in your body. This helps ensure its effectiveness in managing your condition. If you are taking gabapentin more than once a day, try to take it at the same times each day to establish a routine.
  4. Do not stop suddenly: Do not stop taking gabapentin abruptly without consulting your doctor, even if you feel better. Suddenly stopping gabapentin can cause withdrawal symptoms or worsen your condition. Your doctor may need to gradually taper your dose to safely discontinue the medication.
  5. Side effects: Be aware of potential side effects of gabapentin, which may include dizziness, drowsiness, fatigue, blurred vision, weight gain, or swelling in the extremities. If you experience severe or persistent side effects, contact your doctor.
  6. Interactions: Inform your doctor about all medications, supplements, and herbal products you are taking, as gabapentin can interact with certain drugs. This includes over-the-counter medications.
  7. Pregnancy and breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and benefits of taking gabapentin with your doctor. Gabapentin may not be suitable during pregnancy or while breastfeeding.

Aurobindo Pharma

Aurobindo Pharma is a major Indian multinational pharmaceutical company that develops, manufactures, and distributes a wide range of generic pharmaceuticals and active pharmaceutical ingredients (APIs). Here’s a detailed overview of the company:

Company Overview

  1. Founding and History:
    • Founded: In 1986 by Mr. P. V. Ramprasad Reddy and Mr. K. Nityananda Reddy.
    • Headquarters: Hyderabad, Telangana, India.
    • Growth: Aurobindo Pharma has grown rapidly since its inception and is now one of the largest pharmaceutical companies in India and a significant player in the global market.
  2. Operations and Facilities:
    • Manufacturing: Aurobindo has several manufacturing facilities across India, the United States, and other countries. These facilities are compliant with international regulatory standards such as the U.S. FDA, EMA, and WHO.
    • Research and Development: The company invests heavily in R&D with multiple state-of-the-art facilities in India and overseas, focusing on developing generic formulations, APIs, and biosimilars.
  3. Product Portfolio:
    • Generics: Aurobindo offers a broad range of generic medications covering various therapeutic areas, including antibiotics, antiretrovirals, cardiovascular, central nervous system, gastroenterology, and anti-diabetics.
    • APIs: The company is a significant producer of active pharmaceutical ingredients used both in-house and by other pharmaceutical manufacturers.
    • Biosimilars and Specialty Products: Aurobindo is also involved in developing biosimilars and specialty pharmaceuticals, expanding its product offerings beyond traditional generics.
  4. Global Presence:
    • Market Reach: Aurobindo Pharma has a significant presence in over 150 countries, including key markets like the United States, Europe, and emerging markets in Asia and Africa.
    • Subsidiaries: The company operates through numerous subsidiaries and joint ventures worldwide to strengthen its market position and distribution network.

Key Areas of Operation

  1. Regulatory Compliance:
    • Quality Standards: Aurobindo adheres to stringent quality control measures and regulatory requirements to ensure the safety, efficacy, and quality of its products.
    • Approvals and Inspections: The company regularly undergoes inspections by regulatory authorities such as the FDA, EMA, and others to maintain compliance with international standards.
  2. Research and Development:
    • Innovation: Aurobindo’s R&D efforts are focused on developing complex generics, novel drug delivery systems, and biosimilars.
    • Pipeline: The company has a robust pipeline of products in various stages of development, aimed at addressing unmet medical needs and expanding its market offerings.
  3. Manufacturing Excellence:
    • Capacity: Aurobindo’s manufacturing facilities are equipped with advanced technology and have large production capacities, enabling the company to meet global demand efficiently.
    • Vertical Integration: The company’s vertical integration in API and formulation manufacturing provides cost advantages and ensures consistent supply chain management.
  4. Strategic Acquisitions and Partnerships:
    • Expansion: Aurobindo has expanded its global footprint through strategic acquisitions and partnerships, enhancing its product portfolio and market access.
    • Notable Acquisitions: Examples include the acquisition of Sandoz’s U.S. dermatology and oral solids businesses, and Apotex’s businesses in select European countries.

Corporate Responsibility

  1. Sustainability:
    • Environmental Practices: Aurobindo is committed to sustainable manufacturing practices, including reducing its carbon footprint, efficient waste management, and water conservation efforts.
    • Community Initiatives: The company engages in various CSR activities focused on healthcare, education, and community development.
  2. Employee Welfare:
    • Workplace Safety: Aurobindo places a strong emphasis on workplace safety, health, and well-being of its employees.
    • Training and Development: The company invests in continuous training and professional development for its workforce.

Conclusion

Aurobindo Pharma is a prominent global pharmaceutical company known for its extensive range of generic medications and APIs. With a strong focus on research and development, regulatory compliance, and strategic growth, Aurobindo continues to expand its global presence and product portfolio. The company’s commitment to quality, innovation, and sustainability positions it as a key player in the pharmaceutical industry, contributing to making healthcare more affordable and accessible worldwide.